Intec Pharma Ltd. (NTEC) financial statements (2021 and earlier)

Company profile

Business Address 12 HARTOM STREET
JERUSALEM, 777512
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1041
Cash and cash equivalents 939
Short-term investments 11
Receivables 43
Total current assets: 1444
Noncurrent Assets
Operating lease, right-of-use asset 1
Property, plant and equipment 312
Other noncurrent assets 45
Other undisclosed noncurrent assets  0
Total noncurrent assets: 818
TOTAL ASSETS: 2162
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 55
Accounts payable 00
Accrued liabilities 33
Employee-related liabilities 11
Other undisclosed accounts payable and accrued liabilities 1 
Other undisclosed current liabilities 43
Total current liabilities: 88
Noncurrent Liabilities
Long-term debt and lease obligation 1 
Operating lease, liability 1
Liabilities, other than long-term debt 10
Other liabilities 10
Total noncurrent liabilities: 10
Total liabilities: 108
Stockholders' equity
Stockholders' equity attributable to parent 1254
Common stock 11
Additional paid in capital 200195
Accumulated deficit (189)(142)
Total stockholders' equity: 1254
TOTAL LIABILITIES AND EQUITY: 2162

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net investment income  1
Other income 2 
Gross profit: 21
Operating expenses (49)(43)
Other undisclosed operating loss  (1)
Operating loss: (47)(43)
Loss from continuing operations before equity method investments, income taxes: (47)(43)
Other undisclosed income (loss) from continuing operations before income taxes 0(0)
Loss from continuing operations before income taxes: (47)(43)
Income tax expense (1)(0)
Net loss available to common stockholders, diluted: (48)(44)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss: (48)(44)
Comprehensive loss, net of tax, attributable to parent: (48)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: